<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3781</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2021.131120</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Correlation of HBA1C with UACR and Serum Creatinine Level in Type 2 Diabetes Mellitus&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>D</surname><given-names>Hawale</given-names></name></contrib><contrib contrib-type="author"><name><surname>R</surname><given-names>Ambad</given-names></name></contrib><contrib contrib-type="author"><name><surname>S</surname><given-names>Hadke</given-names></name></contrib><contrib contrib-type="author"><name><surname>A</surname><given-names/></name></contrib></contrib-group><pub-date pub-type="ppub"><day>4</day><month>06</month><year>2021</year></pub-date><volume>1)</volume><issue/><fpage>188</fpage><lpage>192</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Diabetes mellitus (DM) is a major emerging clinical health problem in this world. It is a clinical syndrome characterized by hyperglycaemia due to absolute or relative deficiency of insulin. Type 2 DM comprises about 90% of the diabetic population of any country. Diabetic nephropathy is a chronic microvascular complication of poorly controlled diabetes mellitus (DM), leading to end-stage renal disease (ESRD). Diabetic nephropathy is estimated to turn into the most frequent cause of ESRD in the developing world. About 20% to 30% of people with either type 1 or type 2 diabetes develop nephropathy, whose incidence increases with the duration of diabetes. Objective: To check the association of HbA1c (a marker for glycemic control) __ampersandsignamp; two early markers of renal functional impairments: ACR (reflection of MA) serum creatinine in Type 2DM. Methods: This study was a case-control study, conducted in the Medicine Department at DMMC __ampersandsignamp; SMHRC, Nagpur in collaboration with ABVRH, Sawangi (Meghe) from September 2020 to November 2020. In the present study, the total number of subjects included was 100 having an age group between 41-70. The subjects were grouped into two types Group 1: 50 (control) Healthy Individuals Group 2: 50 (study) Type 2 diabetes mellitus Results: In the present study mean levels of HbA1c, microalbumin, serum creatinine and UACR were significantly increased in the study group as compared to the control group and also find a correlation of glycosylated Haemoglobin with UACR and serum creatinine levels in type 2 diabetes mellitus patient. Conclusions: Raised HbA1c is associated with urinary ACR. Urinary ACR should be estimated in monitoring risk assessment of Type 2DM in patients with raised HbA1c.&#13;
</p></abstract><kwd-group><kwd> HbA1c</kwd><kwd> U. ACR (Albumin: Creatinine Ratio)</kwd><kwd> serum creatinine</kwd><kwd> Type 2 DM</kwd></kwd-group></article-meta></front></article>
